IGC Pharma Inc (IGC) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 71.73%0.33 | 0.19 | 0.33 | 0.33 | 0.26 |
| Cost Of Revenue | 190.22%0.27 | 0.09 | 0.17 | 0.18 | 0.15 |
| Gross Profit | 38.38%0.06 | 0.10 | 0.15 | 0.15 | 0.10 |
0.98 | - | - | 0.57 | 1.13 | |
| Selling, General, and Administrative | 0.98 | - | - | 0.57 | 1.13 |
| Research and Development | 1.01 | - | - | 1.00 | 0.85 |
| Operating Income/Loss | 33.39%-1.93 | -2.90 | -1.91 | -1.41 | -1.88 |
| Income/Loss From Continuing Operations Before Tax | 12.36%-2.05 | -1.82 | -1.60 | -1.20 | -1.83 |
| Income Tax Expense/Benefit | - | - | - | - | - |
12.36%-2.05 | -1.82 | -1.60 | -1.20 | -1.83 | |
| Attributable To Parent | 12.36%-2.05 | -1.82 | -1.60 | -1.20 | -1.83 |
| Basic Average Shares | 21.04%109.49 | 90.46 | 83.03 | - | 77.63 |
| Diluted Average Shares | 21.04%109.49 | 90.46 | 83.03 | - | 77.63 |
| Basic Earnings Per Share | -0.02 | -0.02 | -0.02 | - | -0.02 |
| Diluted Earnings Per Share | -0.02 | -0.02 | -0.02 | - | -0.02 |